What Is Good Laboratory Practice (GLP) for Researchers
Discover what good laboratory practice (GLP) is and how it ensures high-quality research. Master GLP guidelines for accurate and compliant results.
!Lab technician writing at busy lab bench
---
TL;DR: > > - Good laboratory practice (GLP) is a managerial quality system that oversees organizational processes and documentation in non-clinical safety studies. It requires continuous effort, proper personnel roles, detailed record-keeping, and adherence to jurisdiction-specific regulations to ensure research integrity. Implementing GLP as a daily operational culture safeguards data quality and facilitates regulatory compliance across multiple frameworks.
---
Good laboratory practice (GLP) is one of the most consequential quality frameworks in non-clinical research, yet it remains widely misunderstood by laboratory professionals who encounter it primarily as a regulatory obligation rather than a management system. Many researchers conflate GLP with general lab hygiene or ISO certification, when in fact it is a managerial quality control system governing the planning, conduct, monitoring, recording, reporting, and archiving of non-clinical health and environmental safety studies. This article clarifies the GLP guidelines overview, explains the regulatory frameworks enforcing it across major jurisdictions, and provides concrete guidance on practical implementation for laboratory managers and researchers.
Table of Contents
- Key takeaways
- What is good laboratory practice (GLP): core principles
- Regulatory frameworks and GLP compliance monitoring
- Practical implementation: how GLP improves research integrity
- Common challenges in maintaining GLP compliance
- My perspective on GLP as a quality culture
- How Aresresearchlab supports GLP-compliant research
- FAQ
Key takeaways
| Point | Details | | --- | --- | | GLP is a management system | GLP governs organizational processes and documentation, not just technical lab procedures. | | Multiple roles share GLP responsibility | Test facility management, study directors, and QA personnel each carry distinct, non-delegable GLP obligations. | | Compliance is jurisdiction-specific | FDA, OECD, UKGLP, and EFSA each maintain separate but interoperable enforcement mechanisms. | | Documentation is the core deliverable | Raw data archiving and controlled amendments are as critical as conducting the experiments themselves. | | Compliance requires continuous effort | Recurring inspections every 12 to 30 months mean audit readiness must be built into daily laboratory operations. |
What is good laboratory practice (GLP): core principles
Good laboratory practice is formally defined by the OECD as a managerial quality control system that covers the organizational processes and conditions under which non-clinical health and environmental safety studies are planned, performed, monitored, recorded, reported, and archived. That definition carries weight. GLP is not a set of bench techniques. It is a governance structure that determines how a test facility organizes itself to produce verifiable, reproducible research data.
The good laboratory practice principles rest on four structural pillars that laboratories must maintain simultaneously.
- Test facility management bears the highest-level responsibility for ensuring that GLP principles are implemented across the organization, that qualified personnel are designated, and that resources are adequate to conduct each study properly.
- The study director holds single-point accountability for the conduct and reporting of each individual study. This person approves the study plan, authorizes any amendments, and signs the final report.
- Quality assurance (QA) personnel operate independently of study conduct. Their role is to inspect ongoing studies, audit final reports, and certify that methods and documentation conform to approved study plans and GLP requirements.
- Standard operating procedures (SOPs) document all routine laboratory operations in sufficient detail that a qualified person can replicate any procedure without additional instruction. SOPs are not optional addenda. They are minimum requirements under GLP, and their absence or outdated status constitutes a direct compliance deficiency.
Beyond personnel structure, good laboratory practice principles require that all raw data be documented contemporaneously during study conduct. Amendments to study plans or final reports must be authorized, dated, and justified. Archives must be maintained in controlled conditions that protect data integrity over the study’s regulatory retention period.
Pro Tip: *Assign a dedicated SOP custodian who tracks version control, expiration dates, and staff sign-off records. Inspectors routinely check that personnel working under a given SOP have formally acknowledged its current version.*
Regulatory frameworks and GLP compliance monitoring
Understanding what are GLP standards means understanding the enforcement structures behind them, which vary by jurisdiction but are designed to interoperate through the OECD’s Mutual Acceptance of Data (MAD) system.
!Compliance officer and scientists reviewing audit report
OECD compliance monitoring programs
The OECD Compliance Monitoring Programme (CMP) provides the structural backbone for GLP enforcement in member countries. Facilities in OECD countries undergo GLP compliance verification through national monitoring programs that conduct facility inspections and study audits. A facility achieves GLP-compliant status through an initial implementation inspection and maintains it through recurring periodic checks.
UKGLP monitoring authority
In the United Kingdom, laboratories joining the UKGLP compliance monitoring program receive an implementation inspection within 12 weeks of application, followed by periodic audits conducted every 12 to 30 months depending on the facility’s study profile and risk rating. Inspection reports are issued within 25 working days of the closing meeting and detail required corrective actions with defined response timelines.
FDA enforcement under 21 CFR Part 58
In the United States, the FDA enforces GLP through 21 CFR Part 58, which grants the agency inspection authority over test facilities, personnel records, and raw data. The regulation includes a critical enforcement clause: a facility that refuses to permit inspection has its non-clinical studies disqualified from consideration in any FDA submission. That single provision makes inspection readiness a non-negotiable operational requirement, not a compliance aspiration.
EFSA and the Mutual Acceptance of Data system
At the European level, EFSA’s GLP framework incorporates OECD principles directly into EU law. Data generated by GLP-compliant facilities in OECD member countries are accepted across regulatory jurisdictions under the MAD system, eliminating the need for duplicative testing when the same compound is reviewed in multiple countries. EFSA may independently request audits from national GLP monitoring authorities as part of its regulatory assurance chain, meaning that a facility’s compliance record is subject to scrutiny beyond its home jurisdiction.
| Regulatory Body | Jurisdiction | Inspection Frequency | Enforcement Mechanism | | --- | --- | --- | --- | | OECD CMP | International (member states) | Periodic, risk-based | National program inspections and study audits | | UKGLP | United Kingdom | Every 12 to 30 months | Implementation inspection plus corrective action | | FDA (21 CFR Part 58) | United States | Risk-based | Inspection authority; study disqualification for refusal | | EFSA | European Union | As requested | Audit requests to national monitoring authorities |
Pro Tip: *If your facility submits data to multiple regulatory bodies, map your documentation practices against both FDA 21 CFR Part 58 and OECD principles from the outset. Retrofitting records to meet a second jurisdiction’s requirements after study completion is far more costly than designing for both from the start.*
Practical implementation: how GLP improves research integrity
The importance of good laboratory practice becomes most tangible when translating principles into daily operational practice. Facilities that implement GLP effectively do so through systematic, documented processes rather than through periodic compliance reviews.
- Establish and maintain study-specific protocols. Every study must begin with a written, approved study plan that specifies the purpose, test system, experimental design, statistical methods, and reporting format. Any deviation from the approved plan requires a formal amendment, signed by the study director, before the deviation occurs whenever practicable.
- Document raw data contemporaneously and completely. Raw data includes all original laboratory records, instrument printouts, photographs, and electronic records generated during the study. GLP requires that these records be attributable, legible, contemporaneous, original, and accurate. The ALCOA framework, widely used in regulated research, operationalizes these same requirements.
- Define and train personnel on specific roles. Each staff member must have a documented job description, a record of their qualifications, and current training documentation for every SOP they execute. Staff responsible for operating specialized equipment must have instrument-specific qualification records.
- Calibrate equipment and control environmental conditions. Facility conditions including temperature, humidity, lighting, and biosecurity must be monitored and recorded at appropriate intervals. Equipment calibration schedules must be documented, and out-of-calibration events must be investigated and resolved before affected instruments are returned to service.
- Conduct internal QA audits at scheduled intervals. Internal audits should cover both in-process study phases and final report reviews. QA personnel must document audit findings and communicate them to study directors and test facility management, with written responses required for any identified deviations.
- Maintain controlled archive storage. Archiving strategies are as critical to GLP compliance as conducting experiments. Archives must include the original study plan, all raw data, specimens where applicable, calibration records, and the final report. Access must be restricted, logged, and auditable.
Pro Tip: *Schedule internal QA audits at study midpoints rather than only at study completion. Midpoint audits allow corrective actions to be implemented before the final data package is assembled, reducing the risk of findings that require retrospective amendments.*
Common challenges in maintaining GLP compliance
!Infographic showing GLP key steps and flow
Even well-resourced laboratories encounter systematic difficulties maintaining full GLP compliance between inspection cycles. Recognizing these patterns allows facility management to address them before they become inspection findings.
The most consistently underestimated challenge is the integrity of the complete documentation trail. Laboratories frequently invest in rigorous experimental procedures while allowing documentation gaps to accumulate. A missing instrument calibration record, an unsigned SOP acknowledgment, or an uncontrolled amendment renders otherwise valid data suspect under GLP review. As the OECD explicitly notes, archiving and controlled amendments are foundational requirements, not administrative formalities.
- Staff turnover creates training gaps. When experienced personnel leave, their procedural knowledge often goes undocumented. New staff may execute procedures correctly by observation but lack formal qualification records that satisfy GLP requirements.
- SOP versioning is frequently mismanaged. Laboratories running long-term studies face the specific challenge of managing mid-study SOP updates. GLP requires that studies reference the SOP version in effect at the time of each procedure, which demands a version-controlled system with clear transition records.
- Equipment maintenance records are incomplete. Calibration due dates pass without timely action, or corrective maintenance is performed without formal documentation. Both scenarios create exposure during inspections.
- Preparation becomes reactive rather than proactive. Recurring inspections every 12 to 30 months require sustained organizational focus. Facilities that treat GLP as a pre-inspection exercise rather than a continuous operational standard accumulate compliance debt that becomes difficult to address without significant disruption.
Technology systems, including laboratory information management systems (LIMS), electronic lab notebooks (ELNs), and automated calibration management platforms, substantially reduce the risk of these failures by building traceability into routine workflows. However, the systems themselves must be validated for use in GLP-regulated environments.
*“GLP readiness demands continuous commitment due to recurring inspections and evolving laboratory conditions; periodic audits require sustained organizational focus.”*
When evaluating whether your documentation infrastructure can withstand external scrutiny, the guidance on evaluating third-party lab testing reports published by Aresresearchlab provides a practical framework for assessing the completeness and traceability of research documentation.
My perspective on GLP as a quality culture
I have reviewed quality systems across multiple regulated research environments, and the pattern is consistent. Laboratories that sustain GLP compliance over time do not treat it as a compliance exercise. They treat it as an operational philosophy embedded in how studies are designed, staffed, and documented from the first day of planning.
What I have found particularly revealing is how quickly compliance culture erodes in the absence of visible management commitment. When study directors and QA personnel see that leadership treats audits as bureaucratic obstacles rather than quality verification tools, procedural shortcuts follow. The documentation gaps that appear on inspection reports rarely originate from ignorance. They originate from a culture that systematically deprioritized record integrity.
The emerging shift toward electronic raw data and digital audit trails is genuinely improving GLP readiness for facilities that implement validated systems correctly. A properly configured ELN with audit trail functionality creates contemporaneous, attributable records automatically, removing the human error component from one of GLP’s most critical requirements. However, the validation burden for these systems is non-trivial, and I have seen facilities introduce electronic records without the required validation evidence, which introduces a new category of compliance risk.
The trend toward global harmonization of GLP standards, driven largely by OECD’s MAD framework, is also changing how facilities think about documentation design. Building study records to satisfy the most demanding jurisdiction in your submission portfolio is the correct strategy. It eliminates costly retrofitting and positions the facility well for any regulatory environment it encounters.
My practical advice for laboratory professionals: integrate GLP review into your monthly operational cadence, not your pre-inspection checklist. Assign ownership of each GLP component to a named individual. Measure compliance performance with internal metrics. The facilities that consistently pass inspections without major findings are the ones that have made GLP indistinguishable from how they work every day.
*— Ares*
How Aresresearchlab supports GLP-compliant research
For laboratory professionals managing compliance requirements, the quality of research compounds directly affects the integrity of GLP study data. Aresresearchlab provides research materials produced to documented compound grading standards with full third-party testing, giving laboratories the traceability documentation required to substantiate compound identity and purity in GLP study records.
Each compound supplied by Aresresearchlab is accompanied by third-party certificates of analysis (COAs). For laboratories building or auditing their GLP documentation packages, the Research Compound COA Checklist provides a structured tool for verifying that incoming compound documentation meets the traceability standards required under GLP archiving requirements. Understanding compound purity data is also addressed in depth through Aresresearchlab’s primer on peptide purity standards, which explains HPLC and mass spectrometry data interpretation relevant to GLP study documentation. Aresresearchlab also offers SRM testing methodology guidance to support accuracy verification in analytical research settings.
FAQ
What is good laboratory practice (GLP) in research?
Good laboratory practice (GLP) is a managerial quality control system that governs the organizational processes and conditions under which non-clinical health and environmental safety studies are planned, conducted, monitored, recorded, reported, and archived, as defined by the OECD.
How does GLP differ from ISO laboratory standards?
GLP is a regulatory framework specifically governing non-clinical safety study conduct and documentation, while ISO standards such as ISO/IEC 17025 address general laboratory competence and technical capability. Both may apply to the same facility but serve distinct regulatory purposes.
What triggers an FDA inspection under 21 CFR Part 58?
The FDA may inspect any test facility conducting studies intended for regulatory submission, and facilities that refuse inspection risk disqualification of their non-clinical studies from consideration in any federal submission.
How often do GLP facilities undergo compliance audits?
In the United Kingdom, UKGLP periodic audits occur every 12 to 30 months depending on the facility’s risk profile, while OECD member state programs apply comparable recurring inspection cycles.
What are the most common GLP compliance failures?
The most frequent failures involve incomplete raw data documentation, missing or unauthorized SOP amendments, lapsed equipment calibration records, and insufficient training documentation for personnel executing regulated procedures.